Nuzenio

Raps Recon

Raps Recon entity intelligence is not indexable yet because Nuzenio needs more live source-attributed coverage.

topic 5 latest news signals 1 publisher sources 100/100 entity strength

Latest news

Recon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS - RAPSRAPS · Thu, 06 Aug 2026 18:15:00 GMTRecon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca - RAPSRAPS · Tue, 04 Aug 2026 20:19:00 GMTRecon: AstraZeneca, BMS discuss merger; FDA broadens indication for Novartis’ Pluvicto - RAPSRAPS · Mon, 03 Aug 2026 16:51:00 GMTRecon: FDA adcomm votes against Capricor’s DMD drug; Cytokinetics gets UK approval, NICE backing for heart drug - RAPSRAPS · Thu, 30 Jul 2026 19:25:00 GMTRecon: WHO releases first interim list of medical device authorities; AstraZeneca using AI to hedge late-stage risks - RAPSRAPS · Mon, 27 Jul 2026 17:44:00 GMT

Timeline

Thu, 06 Aug 2026 18:15:00 GMTRecon: FDA approves first drug for type 1 narcolepsy, mRNA flu vaccine; No merger talks between AstraZeneca-BMS - RAPS
Tue, 04 Aug 2026 20:19:00 GMTRecon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca - RAPS
Mon, 03 Aug 2026 16:51:00 GMTRecon: AstraZeneca, BMS discuss merger; FDA broadens indication for Novartis’ Pluvicto - RAPS
Thu, 30 Jul 2026 19:25:00 GMTRecon: FDA adcomm votes against Capricor’s DMD drug; Cytokinetics gets UK approval, NICE backing for heart drug - RAPS
Mon, 27 Jul 2026 17:44:00 GMTRecon: WHO releases first interim list of medical device authorities; AstraZeneca using AI to hedge late-stage risks - RAPS

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Raps Recon.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

1 distinct publisher/source names are currently connected to this entity page.